99
Views
5
CrossRef citations to date
0
Altmetric
Review

The Top 100 Most Frequently Cited Publications Concerning Anti-PD-1/PD-L1 Therapy for Lung Cancer: A Bibliometric Analysis

, , , , &
Pages 1383-1393 | Published online: 12 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Arezoo Ghamgosar, Sirous Panahi & Leila Nemati-Anaraki. (2023) Cancer and COVID-19 research studies with team science: a bibliometric study. Journal of Interprofessional Care 37:4, pages 568-575.
Read now

Articles from other publishers (4)

Ahmed Abdou, Manal Matoug‐Elwerfelli, Venkateshbabu Nagendrababu, Hani Nazzal & Monty Duggal. (2022) Tooth auto‐transplantation: A bibliometric analysis of the top 100 most‐cited articles. Dental Traumatology 39:1, pages 64-81.
Crossref
Yanhao Liu, Xu Cheng, Xiaona Han, Xi Cheng, Shu Jiang, Yaru Lin, Zhen Zhang, Linlin Lu, Baozhen Qu, Yuxian Chen & Xiaotao Zhang. (2022) Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis. Frontiers in Immunology 13.
Crossref
Yanhao Liu, Yan Xu, Xi Cheng, Yaru Lin, Shu Jiang, Haiming Yu, Zhen Zhang, Linlin Lu & Xiaotao Zhang. (2022) Research Trends and Most Influential Clinical Studies on Anti-PD1/PDL1 Immunotherapy for Cancers: A Bibliometric Analysis. Frontiers in Immunology 13.
Crossref
Yiting Sun, Liqing Jiang, Ti Wen, Xiaoyu Guo, Xinye Shao, Hui Qu, Xi Chen, Yujia Song, Fang Wang, Xiujuan Qu & Zhi Li. (2021) Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study. Frontiers in Pharmacology 12.
Crossref